Money Lancer
← Equity: Sectoral-Pharma and Healthcare
HDFC Mutual Fund
HDFC Mutual Fund · Equity: Sectoral-Pharma and Healthcare

HDFC Pharma And Healthcare Fund - Growth Option

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.

EquityBenchmark · BSE Healthcare TRITER · 2.11%Inception · 04-10-2023
NAV
₹20.53
-1.05% · as of 14-10-2026
Since inception
26.93%
CAGR
Benchmark (inception)
14.55%
CAGR
Fund size
₹3,501 Cr
AUM
Expense ratio
2.11%
29-09-2026
Performance

Returns vs benchmark & category

Since inception: +26.93% CAGR vs benchmark +14.55%.

Portfolio

Where the money is invested

Top holdings

SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-9.96%
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-7.16%
MAX HEALTHCARE INSTITUTE LIMITED EQ5.57%
LUPIN LIMITED EQ NEW F.V. RS.2/-5.26%
CIPLA LIMITED EQ NEW FV RS.2/-5.19%
ASTER DM HEALTHCARE LIMITED EQ5.05%
Ami Organics Limited4.58%
ALKEM LABORATORIES LIMITED EQ4.00%
ANTHEM BIOSCIENCES PRIVATE LIMITED EQ NEW FV Rs. 2/-3.81%
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-3.53%

Sector allocation

Healthcare97.25%
Riskometer
LowVery High
Very High

What if you'd SIP'd here?

@ 26.9% p.a.
₹10,000
10 years
Projected value
₹60,78,837
Invested: ₹12,00,000
Gained: ₹48,78,837
Start this SIP →

Illustration based on fund's since-inception return. Past performance is not indicative of future returns.

Risk Analysis

How this fund manages risk

Fund manager
N
Nikhil Mathur, Bhagyesh Kagalkar
Manager since fund inception data not available
ISIN & identifiers
AMFI code
152084
ISIN (Growth)
INF179KC1HL7
ISIN (Div Re-inv)
—
Status
Open Ended Schemes
Peers

Other Equity: Sectoral-Pharma and Healthcare funds

Want a personalised recommendation?

Our team will tell you whether this fund fits your goals, allocation and risk profile — and suggest peers if it doesn't.

Chat with us